 |
|
|
|
|
|
|
|
|
|
 |
|
||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
|
||||||||
|
|||||||||||||||||||||||||||||||||||||
Habitrol: PatchHaving nicotine transdermal system as a generic name, habitrol, is a kind of smoking deterrent drug with a chemical classification of ganglionic cholinergic. It is bind to acetylcholine receptor at autonomic ganglia in the adrenal medulla, at neuromuscular junctions in the brain to deter cigarette smoking addiction. Habitrol may be given to patients with 15 mg dosage every day in 12 weeks, 10 mg dosage every day for 2 weeks, and 5 mg every day for 2 weeks. It may also be advised by doctors to be taken in with 22 mg dosage every day for 4 to 8 weeks, and 11 mg dosage every day for 2 to 4 weeks. Habitrol or nicotine transdermal system are available in transdermal patch form delivering 7 mg, 14 mg, 21 mg, 10 mg, 5 mg, 22 mg, and 11 mg depending on the product. This medicine may cause patients to have cough, pharyngitis, and sinusitis. Patients may also feel back pain and chest pain upon receiving these medication. Erythema, pruritus, burning at application site, cutaneous hypersensitivity, sweating and rash may also occur after the patch is applied. Patients may also experience diarrhea, dyspepsia, constipation, nausea, abdominal pain and vomiting as side effects, together with having a dry mouth and abnormal taste. They also will most likely have abnormal dreams, insomnia, nervousness, headache, dizziness, paresthesia (commonly known as the feeling of pins and needles), or a sensation of tingling, pricking, or numbness of the skin with no apparent long-term physical effect, arthralgia (literally: "joint pain", from the words "arthros" which means "joint" and "-algia" denoting "pain"), or the presence of painful joints in the absence of frank arthritis, and myalgia or muscle pain. Medical practitioners must be not, in any case, prescribe these medical patches to those with hypersensitivity, children, pregnant or expectant moms, and non-smokers. They also should not recommend these kind of medicine to patients suffering from immediate postmyocardial infraction period, life-threathening dysrhythmias, and severe or worsening angina pectoris. Doctors must be extra careful in prescribing this nicotine patch to patients with suffering from skin disease, angina pectoris, renal or hepatic insuffieciency, peptic ulcer, accelerated hypertension, serious cardiac dysrhythmias, hyperthyroidism, pheochromocytoma, and insulin-dependent diabetes. They also should be cautious to recommend habitrol to the elderly. A decrease in the absorption of glutethimide will take place upon receiving habitrol. There should also be a decrease in the dosage of acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propanolol, theophylline, insulin, and adrenergic antagonists at cessation of smoking. Metabolism of propoxyphene will also decrease after uasge of this medical patch. On the other hand, there will be an increased dose of adrenergic agonists at cessation of smoking. Diuretic effects of furosemide and absorption of SC insulin will also increase. Medical practiotioners must always put into consideration adverse reactions such as irritation, pruritus, and burning at the patch site when assessing the effects and progress of habitrol. In evaluating the patients, doctores must attach a value to their (patients) therapeutic response which includes the decrease in urge of the patient to smoke and the absence of nicotine withdrawal symptoms. After prescribing such medicine, medical practitioners must educate their patients and their patients’ families about all aspects of the drug. They may they may give package insert to patients and explain its contents. They should remind the patients and their families that the patch is as toxic as cigarettes that it should only be used to deter smoking. Smokers must be compelled to stop smoking immediately after they start or on the beginning of their patch treatment. They must warn their patients not to use, in any case, the medical patch during pregnancy; that patients should keep used and unused system out of reach of children and pets; that they (patients) may only apply the product once a day to a non-hairy, clean, and dry area of the skin on upper body, preferably the outer arm; and that the medicine must be applied promptly after removal from protected patch, else the product may lose strength. |
Ethinyl Estradiol and Norelgestramin |
|
|
Abacavir |
Home © health-care-information.org. All rights reserved. Diseases | Drugs | Injuries | Medical Tests | Home Remedies | Herbal Medicines |
Disclaimer: Health-Care-Information.org is designed for educational purposes only and is not engaged in rendering medical advice or professional medical services. Any medical or other decisions should be made in consultation with your qualified health care provider. We will not be liable for any complications, injuries or other medical accidents arising from or in connection with the use of or reliance upon any information on this web site.
